MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 30, 2004; DOI: 10.1124/mol.104.002774


0026-895X/04/6605-1103-1112$20.00
Mol Pharmacol 66:1103-1112, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002774v1
66/5/1103    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visan, V.
Right arrow Articles by Grissmer, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visan, V.
Right arrow Articles by Grissmer, S.

Mapping of Maurotoxin Binding Sites on hKv1.2, hKv1.3, and hIKCa1 Channels

Violeta Visan, Ziad Fajloun, Jean-Marc Sabatier, and Stephan Grissmer

Department of Applied Physiology, University of Ulm, Ulm, Germany (V.V., S.G.); Laboratoire International Associé d'Ingénierie Biomoléculaire, Centre National de la Recherche Scientifique Unité Mixte Recherche 6560, Marseille, France (Z.F., J.-M.S.)

Maurotoxin (MTX) is a potent blocker of human voltage-activated Kv1.2 and intermediate-conductance calcium-activated potassium channels, hIKCa1. Because its blocking affinity on both channels is similar, although the pore region of these channels show only few conserved amino acids, we aimed to characterize the binding sites of MTX in these channels. Investigating the pHo dependence of MTX block on current through hKv1.2 channels, we concluded that the block is less pHo - sensitive than for hIKCa1 channels. Using mutant cycle analysis and computer docking, we tried to identify the amino acids through which MTX binds to hKv1.2 and hIKCa1 channels. We report that MTX interacts with hKv1.2 mainly through six strong interactions. Lys23 from MTX protrudes into the channel pore interacting with the GYGD motif, whereas Tyr32 and Lys7 interact with Val381, Asp363, and Glu355, stabilizing the toxin onto the channel pore. Because only Val381, Asp363, and the GYGD motif are conserved in hIKCa1 channels, and the replacement of His399 from hKv1.3 channels with a threonine makes this channel MTX-sensitive, we concluded that MTX binds to all three channels through the same amino acids. Glu355, although important, is not essential in MTX recognition. A negatively charged amino acid in this position could better stabilize the toxin-channel interaction and could explain the pHo sensitivity of MTX block on current through hIKCa1 versus hKv1.2 channels.


Received May 17, 2004; accepted July 27, 2004

Address correspondence to: Prof. Dr. Stephan Grissmer, Department of Applied Physiology, University of Ulm, Albert-Einstein-Allee 11, D-89081 Ulm, Germany. E-mail: stephan.grissmer{at}medizin.uni-ulm.de




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Gilquin, S. Braud, M. A. L. Eriksson, B. Roux, T. D. Bailey, B. T. Priest, M. L. Garcia, A. Menez, and S. Gasparini
A Variable Residue in the Pore of Kv1 Channels Is Critical for the High Affinity of Blockers from Sea Anemones and Scorpions
J. Biol. Chem., July 22, 2005; 280(29): 27093 - 27102.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Bagdaany, C. V. F. Batista, N. A. Valdez-Cruz, S. Somodi, R. C. R. de la Vega, A. F. Licea, Z. Varga, R. Gaspar, L. D. Possani, and G. Panyi
Anuroctoxin, a New Scorpion Toxin of the {alpha}-KTx 6 Subfamily, Is Highly Selective for Kv1.3 over IKCa1 Ion Channels of Human T Lymphocytes
Mol. Pharmacol., April 1, 2005; 67(4): 1034 - 1044.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics